Stay updated on Nemtabrutinib in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Nemtabrutinib in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nemtabrutinib in Hematologic Malignancies Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page’s footer revision tag has been updated from v3.5.2 to v3.5.3, indicating a minor site version/release update without changing the clinical trial content.
    Difference
    0.0%
    Check dated 2026-04-24T06:09:45.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T02:38:53.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Richter syndrome added as an alias for Richter's transformation to align terminology on the page.
    Difference
    0.2%
    Check dated 2026-04-02T15:34:19.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. This is a metadata change and does not affect the study details or how the page functions.
    Difference
    0.0%
    Check dated 2026-03-19T05:17:37.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-12T00:47:14.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Added: Revision v3.4.2; removed: the government funding/status notice and Revision v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-11T11:55:53.000Z thumbnail image

Stay in the know with updates to Nemtabrutinib in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nemtabrutinib in Hematologic Malignancies Clinical Trial page.